Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's disease

Noriyoshi Kurihara, Sakamuri V. Reddy, Norie Araki, Seiichi Ishizuka, Keiichi Ozono, Jillian Cornish, Tim Cundy, Frederick R. Singer, G. David Roodman

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

In contrast to normal OCL precursors, pagetic OCL precursors express MVNP and form OCL at physiologic concentrations of 1,25(OH)2D3, as do normal OCL precursors transfected with the MVNP gene. Using a GST-VDR chimeric protein, we identified TAFII-17 as VDR binding protein expressed by pagetic OCL precursors and MVNP transduced normal OCL precursors. TAFII-17 was in part responsible for the increased 1,25(OH) 2D3 responsivity of pagetic OCL precursors. Introduction: Pagetic osteoclasts (OCLs) and their precursors express measles virus nucleocapsid protein (MVNP) and form large numbers of OCLs at low concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. Similarly, normal OCL precursors transfected with MVNP also form OCLs at low concentrations of 1,25(OH)2D3. These results suggest that expression of MVNP in OCL precursors enhances vitamin D receptor (VDR)-mediated gene transcription. Materials and Methods: To determine the mechanism for the increased OCL formation capacity of pagetic OCL precursors in response to 1,25(OH)2D3, lysates from pagetic and MVNP-transduced normal OCL precursors were incubated with a GST-VDR chimeric protein. Results: A 17-kDa peptide that bound VDR was detected in MVNP-transduced cells and pagetic OCL precursors treated with 1,25(OH)2D3. This peptide was identified as TAFII-17, a component of the TFIID transcription complex. Expression of increased levels of TAFII-17 in cells allowed TAFII-17 to bind to VDR at low concentrations of 1,25(OH) 2D3. An antisense oligonucelotide (AS-ODN) to TAF II-17 significantly decreased OCL formation in response to 1,25(OH)2D3 in pagetic but not normal marrow cultures by ∼40%. Transfection of TAFII-17 or MVNP into NIH3T3 cells increased VDR transcriptional activity as measured by DR-3 reporter assays. Conclusion: These data show that expression of the MVNP gene in OCL precursors results in increased levels of TAFII-17. TAFII-17 can bind VDR at low concentrations of 1,25(OH)2D3. These results suggest that MVNP expression in Paget's OCL precursors increases expression of a component(s) of the VDR transcription complex that can increase OCL formation.

Original languageEnglish (US)
Pages (from-to)1154-1164
Number of pages11
JournalJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Volume19
Issue number7
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Vitamin D-Binding Protein
Calcitriol Receptors
Osteoclasts
measles virus nucleocapsid protein
Transcription Factor TFIID

Keywords

  • 1,25-dihydroxyvitamin D
  • Bone marrow cultures
  • Osteoclast formation
  • Paget's disease
  • TAF-17

ASJC Scopus subject areas

  • Surgery

Cite this

Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's disease. / Kurihara, Noriyoshi; Reddy, Sakamuri V.; Araki, Norie; Ishizuka, Seiichi; Ozono, Keiichi; Cornish, Jillian; Cundy, Tim; Singer, Frederick R.; Roodman, G. David.

In: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Vol. 19, No. 7, 07.2004, p. 1154-1164.

Research output: Contribution to journalArticle

Kurihara, Noriyoshi ; Reddy, Sakamuri V. ; Araki, Norie ; Ishizuka, Seiichi ; Ozono, Keiichi ; Cornish, Jillian ; Cundy, Tim ; Singer, Frederick R. ; Roodman, G. David. / Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's disease. In: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2004 ; Vol. 19, No. 7. pp. 1154-1164.
@article{2e575de013d84263a672788d5691082a,
title = "Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's disease",
abstract = "In contrast to normal OCL precursors, pagetic OCL precursors express MVNP and form OCL at physiologic concentrations of 1,25(OH)2D3, as do normal OCL precursors transfected with the MVNP gene. Using a GST-VDR chimeric protein, we identified TAFII-17 as VDR binding protein expressed by pagetic OCL precursors and MVNP transduced normal OCL precursors. TAFII-17 was in part responsible for the increased 1,25(OH) 2D3 responsivity of pagetic OCL precursors. Introduction: Pagetic osteoclasts (OCLs) and their precursors express measles virus nucleocapsid protein (MVNP) and form large numbers of OCLs at low concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. Similarly, normal OCL precursors transfected with MVNP also form OCLs at low concentrations of 1,25(OH)2D3. These results suggest that expression of MVNP in OCL precursors enhances vitamin D receptor (VDR)-mediated gene transcription. Materials and Methods: To determine the mechanism for the increased OCL formation capacity of pagetic OCL precursors in response to 1,25(OH)2D3, lysates from pagetic and MVNP-transduced normal OCL precursors were incubated with a GST-VDR chimeric protein. Results: A 17-kDa peptide that bound VDR was detected in MVNP-transduced cells and pagetic OCL precursors treated with 1,25(OH)2D3. This peptide was identified as TAFII-17, a component of the TFIID transcription complex. Expression of increased levels of TAFII-17 in cells allowed TAFII-17 to bind to VDR at low concentrations of 1,25(OH) 2D3. An antisense oligonucelotide (AS-ODN) to TAF II-17 significantly decreased OCL formation in response to 1,25(OH)2D3 in pagetic but not normal marrow cultures by ∼40{\%}. Transfection of TAFII-17 or MVNP into NIH3T3 cells increased VDR transcriptional activity as measured by DR-3 reporter assays. Conclusion: These data show that expression of the MVNP gene in OCL precursors results in increased levels of TAFII-17. TAFII-17 can bind VDR at low concentrations of 1,25(OH)2D3. These results suggest that MVNP expression in Paget's OCL precursors increases expression of a component(s) of the VDR transcription complex that can increase OCL formation.",
keywords = "1,25-dihydroxyvitamin D, Bone marrow cultures, Osteoclast formation, Paget's disease, TAF-17",
author = "Noriyoshi Kurihara and Reddy, {Sakamuri V.} and Norie Araki and Seiichi Ishizuka and Keiichi Ozono and Jillian Cornish and Tim Cundy and Singer, {Frederick R.} and Roodman, {G. David}",
year = "2004",
month = "7",
doi = "10.1359/JBMR.040312",
language = "English (US)",
volume = "19",
pages = "1154--1164",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's disease

AU - Kurihara, Noriyoshi

AU - Reddy, Sakamuri V.

AU - Araki, Norie

AU - Ishizuka, Seiichi

AU - Ozono, Keiichi

AU - Cornish, Jillian

AU - Cundy, Tim

AU - Singer, Frederick R.

AU - Roodman, G. David

PY - 2004/7

Y1 - 2004/7

N2 - In contrast to normal OCL precursors, pagetic OCL precursors express MVNP and form OCL at physiologic concentrations of 1,25(OH)2D3, as do normal OCL precursors transfected with the MVNP gene. Using a GST-VDR chimeric protein, we identified TAFII-17 as VDR binding protein expressed by pagetic OCL precursors and MVNP transduced normal OCL precursors. TAFII-17 was in part responsible for the increased 1,25(OH) 2D3 responsivity of pagetic OCL precursors. Introduction: Pagetic osteoclasts (OCLs) and their precursors express measles virus nucleocapsid protein (MVNP) and form large numbers of OCLs at low concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. Similarly, normal OCL precursors transfected with MVNP also form OCLs at low concentrations of 1,25(OH)2D3. These results suggest that expression of MVNP in OCL precursors enhances vitamin D receptor (VDR)-mediated gene transcription. Materials and Methods: To determine the mechanism for the increased OCL formation capacity of pagetic OCL precursors in response to 1,25(OH)2D3, lysates from pagetic and MVNP-transduced normal OCL precursors were incubated with a GST-VDR chimeric protein. Results: A 17-kDa peptide that bound VDR was detected in MVNP-transduced cells and pagetic OCL precursors treated with 1,25(OH)2D3. This peptide was identified as TAFII-17, a component of the TFIID transcription complex. Expression of increased levels of TAFII-17 in cells allowed TAFII-17 to bind to VDR at low concentrations of 1,25(OH) 2D3. An antisense oligonucelotide (AS-ODN) to TAF II-17 significantly decreased OCL formation in response to 1,25(OH)2D3 in pagetic but not normal marrow cultures by ∼40%. Transfection of TAFII-17 or MVNP into NIH3T3 cells increased VDR transcriptional activity as measured by DR-3 reporter assays. Conclusion: These data show that expression of the MVNP gene in OCL precursors results in increased levels of TAFII-17. TAFII-17 can bind VDR at low concentrations of 1,25(OH)2D3. These results suggest that MVNP expression in Paget's OCL precursors increases expression of a component(s) of the VDR transcription complex that can increase OCL formation.

AB - In contrast to normal OCL precursors, pagetic OCL precursors express MVNP and form OCL at physiologic concentrations of 1,25(OH)2D3, as do normal OCL precursors transfected with the MVNP gene. Using a GST-VDR chimeric protein, we identified TAFII-17 as VDR binding protein expressed by pagetic OCL precursors and MVNP transduced normal OCL precursors. TAFII-17 was in part responsible for the increased 1,25(OH) 2D3 responsivity of pagetic OCL precursors. Introduction: Pagetic osteoclasts (OCLs) and their precursors express measles virus nucleocapsid protein (MVNP) and form large numbers of OCLs at low concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. Similarly, normal OCL precursors transfected with MVNP also form OCLs at low concentrations of 1,25(OH)2D3. These results suggest that expression of MVNP in OCL precursors enhances vitamin D receptor (VDR)-mediated gene transcription. Materials and Methods: To determine the mechanism for the increased OCL formation capacity of pagetic OCL precursors in response to 1,25(OH)2D3, lysates from pagetic and MVNP-transduced normal OCL precursors were incubated with a GST-VDR chimeric protein. Results: A 17-kDa peptide that bound VDR was detected in MVNP-transduced cells and pagetic OCL precursors treated with 1,25(OH)2D3. This peptide was identified as TAFII-17, a component of the TFIID transcription complex. Expression of increased levels of TAFII-17 in cells allowed TAFII-17 to bind to VDR at low concentrations of 1,25(OH) 2D3. An antisense oligonucelotide (AS-ODN) to TAF II-17 significantly decreased OCL formation in response to 1,25(OH)2D3 in pagetic but not normal marrow cultures by ∼40%. Transfection of TAFII-17 or MVNP into NIH3T3 cells increased VDR transcriptional activity as measured by DR-3 reporter assays. Conclusion: These data show that expression of the MVNP gene in OCL precursors results in increased levels of TAFII-17. TAFII-17 can bind VDR at low concentrations of 1,25(OH)2D3. These results suggest that MVNP expression in Paget's OCL precursors increases expression of a component(s) of the VDR transcription complex that can increase OCL formation.

KW - 1,25-dihydroxyvitamin D

KW - Bone marrow cultures

KW - Osteoclast formation

KW - Paget's disease

KW - TAF-17

UR - http://www.scopus.com/inward/record.url?scp=15244347056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15244347056&partnerID=8YFLogxK

U2 - 10.1359/JBMR.040312

DO - 10.1359/JBMR.040312

M3 - Article

C2 - 15176999

AN - SCOPUS:15244347056

VL - 19

SP - 1154

EP - 1164

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 7

ER -